Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2 - Siebert, N; Eger, C; Seidel, D (MAbs, 2016)
et al.